First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines
Beilinson Hospital in Petah Tikva. Prof. Salomon Stemmer, Director of the Oncology Research Unit at Davidoff Center, Beilinson Hospital: “We found that there is a high enough level of antibodies to provide full protection for 90% of oncology patients undergoing active anti-cancer treatment.” Israeli researchers have been examining the relationship between the COVID-19 vaccine (messenger RNA SARS-CoV-2) and patients undergoing treatment for various types of cancer. The findings suggest that patients with cancer who are receiving active treatment and are at higher risk for severe COVID-19 d...
Source: ejpress.org